A multi centre randomised controlled trial comparing intra operative cell salvage with standard care in the treatment of hip fractures
Not Applicable
- Conditions
- Fracture of neck of femurInjury, Occupational Diseases, Poisoning
- Registration Number
- ISRCTN15945622
- Lead Sponsor
- niversity Hospitals Coventry and Warwickshire NHS Trust
- Brief Summary
2022 Protocol article in https://pubmed.ncbi.nlm.nih.gov/35676006/ (added 09/06/2022)
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 1128
Inclusion Criteria
Participants of 60 years of age and older who have sustained a fracture of the hip who, in the opinion of the operating surgeon, would benefit from surgery
Exclusion Criteria
1. Patients younger than 60 years of age
2. Patients undergoing percutaneous hip screw fixation
3. Patients who have sustained a pathological fracture
4. Patients for whom the treating surgeon has already elected to use cell salvage (for example Jehovah Witness)
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br> Current primary outcome measure as of 08/04/2020:<br><br> Health-related quality of life measured using the EuroQol 5 dimension(EQ-5D-5L) score at baseline (retrospective pre-fracture status) and 4 months post-operatively<br><br> _____<br> Previous primary outcome measure:<br> 1. Recruitment rate per centre<br> 2. The number of patients for whom autotransfusion is possible<br> 3. The volume of blood autotransfused<br>
- Secondary Outcome Measures
Name Time Method